Order of the President of the Court of First Instance of 24 April 2009 — Nycomed Danmark v EMEA

(Case T-52/09 R)

(Application for interim measures - Marketing authorisation for a medicinal product - Ultrasound echocardiographic imaging agent for diagnostic purposes (perflubutane) - Refusal by the EMEA to grant a waiver from the obligation to submit a paediatric investigation plan - Application for suspension of operation of a measure and interim measures - No urgency)

2009/C 141/91

Language of the case: English

Parties

Applicant: Nycomed Danmark ApS (Roskilde, Denmark) (represented by: C. Schoonderbeek and H. Speyart van Woerden, lawyers)

Defendant: European Medicines Agency (EMEA) (represented by: V. Salvatore and N. Rampal Olmedo, Agents)

Re:

APPLICATION, first, for suspension of the operation of the EMEA’s decision of 28 November 2008 rejecting the application for a product-specific waiver concerning perflubutane and, secondly, for the grant of interim measures.

Operative part of the order